7:32 am Anacor Pharma announces successful completion of End-of-Phase 2 meeting with FDA for the treatment of mild-to-moderate atopic dermatitis with AN2728
View todays social media effects on ANAC
View the latest stocks trending across Twitter. Click to view dashboard
See who Anacor is hiring next, click here to view
